Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice

Autor: Karin M. Egberts, Manfred Gerlach, Christoph U. Correll, Paul L. Plener, Uwe Malzahn, Peter Heuschmann, Stefan Unterecker, Maike Scherf-Clavel, Hans Rock, Gisela Antony, Wolfgang Briegel, Christian Fleischhaker, Alexander Häge, Tobias Hellenschmidt, Harmut Imgart, Michael Kaess, Andreas Karwautz, Michael Kölch, Karl Reitzle, Tobias Renner, Su-Yin Reuter-Dang, Christian Rexroth, Gerd Schulte-Körne, Frank M. Theisen, Susanne Walitza, Christoph Wewetzer, Stefanie Fekete, Regina Taurines, Marcel Romanos

Publikováno v: Egberts, Karin M.; Gerlach, Manfred; Correll, Christoph U.; Plener, Paul L.; Malzahn, Uwe; Heuschmann, Peter; Unterecker, Stefan; Scherf-Clavel, Maike; Rock, Hans; Antony, Gisela; Briegel, Wolfgang; Fleischhaker, Christian; Häge, Alexander; Hellenschmidt, Tobias; Imgart, Harmut; Kaess, Michael; Karwautz, Andreas; Kölch, Michael; Reitzle, Karl; Renner, Tobias; ... (2022). Serious Adverse Drug Reactions in Children and Adolescents Treated On-and Off-Label with Antidepressants and Antipsychotics in Clinical Practice. Pharmacopsychiatry, 55(05), pp. 255-265. Thieme 10.1055/a-1716-1856

Introduction Despite the growing evidence base for psychotropic drug treatment in pediatric patients, knowledge about the benefit-risk ratio in clinical practice remains limited. The ‘Therapeutic Drug Monitoring (TDM)-VIGIL’ study aimed to evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fa63a58a5408fdfdb5874125246246